CBRE Group
CBRE
$149.31
-2.74%
CBRE Group, Inc. is the world's largest commercial real estate services and investment firm, providing a comprehensive suite of services including leasing, property and project management, valuation, and capital markets advisory. The company is a dominant global leader in its industry, distinguished by its massive scale, extensive global footprint, and integrated platform that spans advisory, outsourcing, and investment management, with over $155 billion in assets under management. The current investor narrative is intensely focused on the company's resilience and cyclical positioning, as recent market volatility and a sharp correction in its stock price in February 2026 reflect investor concerns over broader economic headwinds impacting commercial real estate transaction volumes and capital markets activity.…
CBRE
CBRE Group
$149.31
CBRE 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on CBRE Group's 12-month outlook, with a consensus price target around $194.10 and implied upside of +30.0% versus the current price.
Average Target
$194.10
2 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
2
covering this stock
Price Range
$119 - $194
Analyst target range
Insufficient analyst coverage available. The provided data indicates only two analysts are providing estimates, which is minimal for a company of CBRE's size and market capitalization. This limited coverage typically implies the stock may be under-followed by the broader institutional research community, which can lead to higher volatility and less efficient price discovery as information is not as widely disseminated and analyzed. The lack of a consensus price target or recommendation distribution prevents a clear read on Wall Street sentiment, placing greater onus on investors to conduct independent fundamental and technical analysis.
Bulls vs Bears: CBRE Investment Factors
The investment debate for CBRE is intensely focused on its cyclical positioning versus its structural resilience. Currently, the bear case holds stronger evidence, driven by the stock's severe technical downtrend, elevated trailing valuation demanding a perfect earnings recovery, and clear signs of revenue growth deceleration. The most critical tension is between the company's dominant, cash-generative franchise and the near-term headwinds from a slowing commercial real estate transaction environment. The resolution of this tension—specifically, whether CBRE's earnings can rebound sufficiently to justify its forward multiple before cyclical pressures intensify—will determine the direction of the stock.
Bullish
- Strong Free Cash Flow Generation: The company generates robust free cash flow, with TTM FCF of $1.193 billion. This provides ample internal funding for operations, debt service, and strategic investments without reliance on external capital, enhancing financial resilience.
- Attractive Forward Valuation: The forward P/E of 17.43x is significantly lower than the trailing P/E of 41.44x, indicating the market expects a substantial earnings recovery. This forward multiple is more reasonable for a cyclical services business and suggests potential upside if earnings meet expectations.
- Dominant Market Position & Scale: As the world's largest commercial real estate services firm with over $155B in AUM, CBRE benefits from an unmatched global footprint and integrated platform. This scale provides competitive advantages in client retention and cross-selling during market cycles.
- Recent Oversold Bounce & Technical Support: The stock has rebounded 13.14% over the past month from deeply oversold levels, suggesting a potential relief rally. With the current price of $151.51 well above the 52-week low of $113.74, a firm technical support level has been established.
Bearish
- Severe Cyclical & Technical Downtrend: The stock is in a pronounced downtrend, down 11.70% over 3 months and underperforming the S&P 500 by -14.37%. Trading at just 62% of its 52-week range near $151.51, it reflects significant negative momentum and investor concerns over the CRE cycle.
- Elevated Trailing Valuation & Thin Margins: The trailing P/E of 41.44x is near the upper end of its historical range, demanding high future growth. Concurrently, Q4 operating margins were thin at 1.87%, highlighting the business's competitive, low-margin nature which pressures profitability during downturns.
- Revenue Growth Deceleration: While Q4 2025 revenue grew 11.77% YoY to $11.629B, this represents a sequential deceleration from stronger prior quarters. This slowdown signals potential headwinds in core transaction and capital markets activities as economic conditions tighten.
- High Volatility & Market Sensitivity: With a beta of 1.35, CBRE is 35% more volatile than the market, and it has experienced a maximum drawdown of -23.22%. This high volatility exposes investors to amplified downside risk during broader market sell-offs or sector-specific fears.
CBRE Technical Analysis
The stock is in a pronounced downtrend, having declined 11.70% over the past three months and 3.57% over the past six months, which contrasts sharply with its positive 28.81% gain over the past year. With a current price of $151.51, CBRE is trading at approximately 62% of its 52-week range (between $113.74 and $174.27), indicating it is much closer to its yearly lows than highs, which may signal a value opportunity but also reflects significant selling pressure and negative momentum. Recent momentum shows a stark divergence, with a strong 13.14% rebound over the past month suggesting a potential oversold bounce or relief rally, yet this short-term strength is set against the backdrop of significant underperformance relative to the S&P 500, as evidenced by its -14.37 relative strength over three months. Key technical support is clearly defined at the 52-week low of $113.74, while resistance sits near the 52-week high of $174.27; a sustained move above the recent recovery highs near $170 would be needed to signal a trend reversal. The stock's beta of 1.35 indicates it is 35% more volatile than the broader market, which is critical for risk assessment, especially given the stock's 23.22% maximum drawdown highlighting its susceptibility to sharp declines during market stress.
Beta
1.35
1.35x market volatility
Max Drawdown
-23.2%
Largest decline past year
52-Week Range
$118-$174
Price range past year
Annual Return
+22.3%
Cumulative gain past year
| Period | CBRE Return | S&P 500 |
|---|---|---|
| 1m | +12.3% | +8.5% |
| 3m | -11.8% | +2.8% |
| 6m | -8.4% | +4.6% |
| 1y | +22.3% | +32.3% |
| ytd | -6.8% | +3.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CBRE Fundamental Analysis
Revenue growth has been robust but shows signs of sequential deceleration; Q4 2025 revenue of $11.629 billion grew 11.77% year-over-year, yet this represents a slowdown from the stronger growth rates seen in prior quarters of 2025. The company's profitability is solid, with Q4 2025 net income of $416 million and a gross margin of 15.29%, though operating margins remain thin at 1.87%, reflecting the competitive, service-intensive nature of the business. The balance sheet and cash flow position is healthy, with trailing twelve-month free cash flow of $1.193 billion providing ample internal funding, a manageable debt-to-equity ratio of 1.13, and a return on equity of 13.03%, indicating efficient use of shareholder capital. The current ratio of 1.09 suggests adequate, though not robust, short-term liquidity to cover obligations.
Quarterly Revenue
$11.6B
2025-12
Revenue YoY Growth
+0.11%
YoY Comparison
Gross Margin
+0.15%
Latest Quarter
Free Cash Flow
$1.2B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CBRE Overvalued?
Given the company's positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE ratio is elevated at 41.44x, while the forward PE is significantly lower at 17.43x, indicating the market expects a substantial earnings recovery in the coming year. Compared to its own historical range, the current trailing PE of 41.44x is near the upper end of its multi-year spectrum, which has seen ratios fluctuate from the teens to over 60x, suggesting the stock is pricing in optimistic future earnings growth rather than trading at a discount. The price-to-sales ratio of 1.18 and EV-to-Sales of 1.28 appear more reasonable for a low-margin services business, but the high trailing PE underscores the market's focus on normalized earnings power post the current cyclical downturn.
PE
41.4x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 12x~75x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
21.7x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: CBRE faces significant margin pressure, with Q4 operating margins at just 1.87%, reflecting the low-margin, service-intensive nature of its business. While free cash flow is strong at $1.193B TTM, the company carries a moderate debt burden with a Debt-to-Equity ratio of 1.13. Revenue concentration in cyclical capital markets and leasing services makes earnings highly volatile, as seen in the fluctuating quarterly net income from $163M in Q1 2025 to $416M in Q4 2025. This dependence on continued transaction volume growth to justify its valuation is a key financial risk.
Market & Competitive Risks: The primary market risk is valuation compression. The stock trades at a trailing P/E of 41.44x, a premium that is vulnerable if the expected earnings recovery is delayed. As a pure-play on commercial real estate, CBRE is highly sensitive to macroeconomic conditions, interest rates, and credit availability. Its beta of 1.35 confirms above-market volatility and correlation to economic cycles. Competitive risks include disruption from technology-enabled platforms and pressure on fee structures, though its massive scale provides some insulation.
Worst-Case Scenario: The worst-case scenario involves a prolonged downturn in commercial real estate transaction volumes coupled with a broader economic recession. This would lead to consecutive quarters of earnings misses, multiple compression, and a breach of technical support. In this adverse scenario, the stock could realistically retest its 52-week low of $113.74, representing a downside of approximately -25% from the current price of $151.51. The -23.22% maximum drawdown already experienced indicates the stock's susceptibility to such sharp declines during market stress.
